Advances in oral high-efficacy disease-modifying drugs in the treatment of multiple sclerosis in remission

doi:10.3969/j.issn.1672-3384.2024.04.002

LIU Yue-yue, FU Rong, WANG Xin, JIA Yu, ZHANG Lan

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (4) : 6-10.

PDF(403 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (4) : 6-10. DOI: 10.3969/j.issn.1672-3384.2024.04.002

Review

Advances in oral high-efficacy disease-modifying drugs in the treatment of multiple sclerosis in remission

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(4): 6-10 https://doi.org/10.3969/j.issn.1672-3384.2024.04.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(403 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-12-28	2024-04-24
Issue Date
2024-04-24

Please choose a citation manager

Content to export